The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole
Abstract
In a prospective observational study of 54 patients with human immunodeficiency virus-associated cryptococcal meningitis, the early fungicidal activity of amphotericin B (1 mg/kg/day) was significantly greater than that of fluconazole (400 mg/day). Compared with antiretroviral therapy-naive patients, patients developing cryptococcal meningitis while already receiving antiretroviral therapy had lower baseline fungal burdens and a longer median duration of survival, but there were no differences observed in fungal clearance, cerebrospinal fluid proinflammatory cytokines, or 10-week mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practice Guidelines for the Management of Cryptococcal Disease
Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D., Dismukes, W. E., & Mycoses Study Group Cryptococcal Subproject (2000) · Clinical Infectious Diseases · doi:10.1086/313757 · Cited by 1,105
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
Brouwer, A. E., Rajanuwong, A., Chierakul, W., Griffin, G. E., Larsen, R. A., White, N. J., & Harrison, T. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16301-0 · Cited by 470
Self-citationLortholary, O., Fontanet, A., Mémain, N., Martin, A., Sitbon, K., & Dromer, F. (2005) · AIDS · doi:10.1097/01.aids.0000174450.70874.30 · Cited by 324
Shelburne, III, Darcourt, J., White, Jr., Greenberg, S. B., Hamill, R. J., Atmar, R. L., & Visnegarwala, F. (2005) · Clinical Infectious Diseases · doi:10.1086/428618 · Cited by 305
Bicanic, T., Harrison, T., Niepieklo, A., Dyakopu, N., & Meintjes, G. (2006) · Clinical Infectious Diseases · doi:10.1086/507895 · Cited by 224
Self-citationLong-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy
Lortholary, O., Poizat, G., Zeller, V., Neuville, S., Boibieux, A., Alvarez, M., Dellamonica, P., Botterel, F., Dromer, F., & Chêne, G. (2006) · AIDS · doi:10.1097/01.aids.0000252060.80704.68 · Cited by 198
Mwaba, P., Mwansa, J., Chintu, C., Pobee, J., Scarborough, M., Portsmouth, S., & Zumla, A. (2001) · Postgraduate Medical Journal · doi:10.1136/pgmj.77.914.769 · Cited by 198
IFN-γ at the Site of Infection Determines Rate of Clearance of Infection in Cryptococcal Meningitis
Siddiqui, A. A., Brouwer, A. E., Wuthiekanun, V., Jaffar, S. S., Shattock, R. J., Irving, D., Sheldon, J., Chierakul, W., Peacock, S. J., Day, N., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1746 · Cited by 146
Self-citationLawn, S. D., Bekker, L., Myer, L., Orrell, C., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000191232.16111.f9 · Cited by 130
Self-citationMayanja‐Kizza, H., Oishi, K., Mitarai, S., Yamashita, H., Nalongo, K., Watanabe, K., Izumi, T., Ococi-Jungala, Augustine, K., Mugerwa, R. D., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516372 · Cited by 128
Cited by
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Self-citationEpidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Maziarz, E. K., & Perfect, J. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.006 · Cited by 698
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
Lawn, S. D., Harries, A. D., Anglaret, X., Myer, L., & Wood, R. (2008) · AIDS · doi:10.1097/qad.0b013e32830007cd · Cited by 639
Self-citationTiming of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
Boulware, D. R., Meya, D. B., Muzoora, C., Rolfes, M. A., Huppler Hullsiek, K., Musubire, A., Taseera, K., Nabeta, H. W., Schutz, C., Williams, D. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312884 · Cited by 497
Self-citationPfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Bijie, H., Dzierzanowska, D., Klimko, N. N., Letscher-Bru, V., Lisalova, M., Muehlethaler, K., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01747-08 · Cited by 370
Jarvis, J. N., Bicanic, T., Loyse, A., Namarika, D., Jackson, A., Nussbaum, J. C., Longley, N., Muzoora, C., Phulusa, J., Taseera, K., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit794 · Cited by 367
Self-citationBoulware, D. R., Rolfes, M. A., Rajasingham, R., von Hohenberg, M., Qin, Z., Taseera, K., Schutz, C., Kwizera, R., Butler, E. K., Meintjes, G., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2001.130906 · Cited by 321
Self-citationJarvis, J. N., Lawn, S. D., Vogt, M., Bangani, N., Wood, R., & Harrison, T. S. (2009) · Clinical Infectious Diseases · doi:10.1086/597262 · Cited by 318
Self-citationKambugu, A., Meya, D. B., Rhein, J., O’Brien, M., Janoff, E. N., Ronald, A. R., Kamya, M. R., Mayanja‐Kizza, H., Sande, M. A., Bohjanen, P. R., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587667 · Cited by 300
Meya, D. B., Manabe, Y. C., Castelnuovo, B., Cook, B. A., Elbireer, A. M., Kambugu, A., Kamya, M. R., Bohjanen, P. R., & Boulware, D. R. (2010) · Clinical Infectious Diseases · doi:10.1086/655143 · Cited by 296
Jarvis, J. N., Percival, A., Bauman, S., Pelfrey, J., Meintjes, G., Williams, G. N., Longley, N., Harrison, T. S., & Kozel, T. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir613 · Cited by 295
Self-citationJarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C., Bekker, L.-G., Wood, R., & Harrison, T. S. (2012) · AIDS · doi:10.1097/qad.0b013e3283536a93 · Cited by 290
Self-citationBoulware, D. R., Meya, D. B., Bergemann, T. L., Wiesner, D. L., Rhein, J., Musubire, A., Lee, S. J., Kambugu, A., Janoff, E. N., & Bohjanen, P. R. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000384 · Cited by 279
Cryptococcal meningitis: epidemiology and therapeutic options
Sloan, D., & Parris, V. (2014) · Clinical Epidemiology · doi:10.2147/clep.s38850 · Cited by 277
Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases
Jarvis, J. N., Meintjes, G., Williams, A., Brown, Y., Crede, T., & Harrison, T. S. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-67 · Cited by 266
Self-citationBrizendine, K. D., Baddley, J. W., & Pappas, P. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060431 · Cited by 265
HIV-associated cryptococcal meningitis
Jarvis, J. N., & Harrison, T. S. (2007) · AIDS · doi:10.1097/qad.0b013e3282a4a64d · Cited by 252
Self-citationBicanic, T., Muzoora, C., Brouwer, A. E., Meintjes, G., Longley, N., Taseera, K., Rebe, K., Loyse, A., Jarvis, J., Bekker, L., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/604716 · Cited by 227
Self-citationRhein, J., Morawski, B. M., Hullsiek, K. H., Nabeta, H. W., Kiggundu, R., Tugume, L., Musubire, A., Akampurira, A., Smith, K. D., Alhadab, A., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00074-8 · Cited by 183
In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus
Shaw, K. J., Schell, W. A., Covel, J., Duboc, G., Giamberardino, C., Kapoor, M., Moloney, M., Soltow, Q. A., Tenor, J. L., Toffaletti, D. L., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00523-18 · Cited by 121
Rhodes, J., Beale, M. A., Vanhove, M., Jarvis, J. N., Kannambath, S., Simpson, J. A., Ryan, A., Meintjes, G., Harrison, T. S., Fisher, M. C., et al. (2017) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.116.037499 · Cited by 100
Self-citationJackson, A. T., Nussbaum, J. C., Phulusa, J., Namarika, D., Chikasema, M., Kanyemba, C., Jarvis, J. N., Jaffar, S., Hosseinipour, M. C., van der Horst, C., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328354b419 · Cited by 86
Self-citationSiderophores: More than Stealing Iron
Behnsen, J., & Raffatellu, M. (2016) · mBio · doi:10.1128/mbio.01906-16 · Cited by 79
Hope, W., Stone, N. R. H., Johnson, A., McEntee, L., Farrington, N., Santoro-Castelazo, A., Liu, X., Lucaci, A., Hughes, M., Oliver, J. D., et al. (2019) · mBio · doi:10.1128/mbio.02575-19 · Cited by 70
Self-citationEfficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
Lu, R., Hollingsworth, C., Qiu, J., Wang, A., Hughes, E., Xin, X., Konrath, K. M., Elsegeiny, W., Park, Y.-D., Atakulu, L., et al. (2019) · mBio · doi:10.1128/mbio.00724-19 · Cited by 67
Villanueva-Lozano, H., Treviño-Rangel, R. D. J., González, G. M., Hernández-Rodríguez, P. A., Camacho-Ortiz, A., Castillo-Reyna, L., Galindo-Alvarado, S. G., & Martínez-Reséndez, M. F. (2018) · Infection · doi:10.1007/s15010-017-1059-3 · Cited by 35
A High-Throughput Screening Assay for Fungicidal Compounds against Cryptococcus neoformans
Rabjohns, J. L. A., Park, Y.-D., Dehdashti, J., Sun, W., Henderson, C., Zelazny, A., Metallo, S. J., Zheng, W., & Williamson, P. R. (2014) · SLAS Discovery · doi:10.1177/1087057113496847 · Cited by 33
“A recent review highlighted the possible superiority of fungicidal versus fungistatic regimens in some infections.6 For example, therapy of cryptococcal meningitis has traditionally been more effective in the early treatment period with amphotericin B–based fungicidal regimens, with improved initial outcomes and more…”
MethodResultInfluential
Metadata
- Authors
- Bicanic, T., Meintjes, G., Wood, R., Hayes, M., Rebe, K., Bekker, L.-G., & Harrison, T.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07-01
- Volume
- 45
- Issue
- 1
- Pages
- 76-80
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2136955446
- Cited by
- 271
- References
- 11
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.